tadalafil has been researched along with Pulmonary Sarcoidosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abston, E; Berman, J; Farber, HW; Govender, P; Hon, S; Lawrence, R | 1 |
1 other study(ies) available for tadalafil and Pulmonary Sarcoidosis
Article | Year |
---|---|
Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy.
Topics: Adult; Aged; Antihypertensive Agents; Arterial Pressure; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Lung Transplantation; Male; Middle Aged; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Pulmonary Artery; Pyridazines; Retrospective Studies; Sarcoidosis, Pulmonary; Tadalafil; Treatment Outcome | 2020 |